STING agonists reduce genital chlamydial infection and attenuate inflammation and pathology
. Importantly, mice exhibited local and systemic tolerance to the STING agonists. Collectively, these findings suggest a novel STING agonist-based approach for controlling chlamydial infection, which could offer a non-antibiotic, mucosally targeted strategy to reduce the risk of hydrosalpinx in exposed women.
Authors
- Q Wang
- Chunfu Yang (ORCID: https://orcid.org/0000-0002-3331-0991)
- Yidan Gao (ORCID: https://orcid.org/0009-0000-7822-5953)
- Yuanshuo Guo
- Haoneng Tang
- Na Cui
- Shuping Hou
- Lijuan Jiang
- Xuemei Wang
- Lingli Tang
- Cuixiu Wu
Institutions
- Central South University (CN)
- Tianjin Medical University General Hospital (CN)
- Southern University of Science and Technology (CN)
- Guizhou Center for Disease Control and Prevention (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Infection and Immunity
- Published
- 2026-04-30
- DOI
- https://doi.org/10.1128/iai.00761-25
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00